Tikun Olam Cannbit Pharmaceuticals Ltd (TKUN) - Total Liabilities
Based on the latest financial reports, Tikun Olam Cannbit Pharmaceuticals Ltd (TKUN) has total liabilities worth ILA27.50 Million ILA (≈ $73.72K USD) as of June 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore Tikun Olam Cannbit Pharmaceuticals Ltd (TKUN) equity growth momentum to track the company's year-over-year net asset growth rate.
Tikun Olam Cannbit Pharmaceuticals Ltd - Total Liabilities Trend (2017–2024)
This chart illustrates how Tikun Olam Cannbit Pharmaceuticals Ltd's total liabilities have evolved over time, based on quarterly financial data.
Tikun Olam Cannbit Pharmaceuticals Ltd Competitors by Total Liabilities
The table below lists competitors of Tikun Olam Cannbit Pharmaceuticals Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Alisa Pankki Oyj
HE:ALISA
|
Finland | €314.51 Million |
|
Laurion Mineral Exploration Inc
V:LME
|
Canada | CA$599.62K |
|
Triumph Gold Corp
V:TIG
|
Canada | CA$242.63K |
|
Obducat AB (publ)
F:OBD
|
Germany | €98.40 Million |
|
Pelangio Exploration Inc
V:PX
|
Canada | CA$543.51K |
|
Pico (Thailand) Public Company Limited
BK:PICO
|
Thailand | ฿259.55 Million |
|
Aquaron Acquisition Corp. Common Stock
NASDAQ:AQU
|
USA | $5.64 Million |
Liability Composition Analysis (2017–2024)
This chart breaks down Tikun Olam Cannbit Pharmaceuticals Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Tikun Olam Cannbit Pharmaceuticals Ltd stock valuation.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 0.20 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | -2.33 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 3.51 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Tikun Olam Cannbit Pharmaceuticals Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Tikun Olam Cannbit Pharmaceuticals Ltd (2017–2024)
The table below shows the annual total liabilities of Tikun Olam Cannbit Pharmaceuticals Ltd from 2017 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ILA29.36 Million ≈ $78.70K |
-32.56% |
| 2023-12-31 | ILA43.53 Million ≈ $116.70K |
+9.09% |
| 2022-12-31 | ILA39.90 Million ≈ $106.98K |
-13.17% |
| 2021-12-31 | ILA45.96 Million ≈ $123.21K |
-21.78% |
| 2020-12-31 | ILA58.75 Million ≈ $157.51K |
+5.75% |
| 2019-12-31 | ILA55.56 Million ≈ $148.94K |
+692.75% |
| 2018-12-31 | ILA7.01 Million ≈ $18.79K |
+1048.85% |
| 2017-12-31 | ILA610.00K ≈ $1.64K |
-- |
About Tikun Olam Cannbit Pharmaceuticals Ltd
Tikun Olam-Cannbit Pharmaceuticals Ltd engages in the cultivation, production, marketing, storage, distribution, export and import, and sale of cannabis-based products in Israel. The company provides medical cannabis products for the treatment and relief of symptoms in a wide variety of medical indications. It also offers training and patient care services. Tikun Olam-Cannbit Pharmaceuticals Ltd … Read more